Scientists have reported progress on AI-designed viruses, raising both excitement and safety concerns. The work uses generative AI to produce full viral genomes that researchers then synthesize in the lab and test for functionality. While the study focuses on bacteriophages—viruses that target bacteria—the capability signals a broader “digital biology” shift toward designing living systems from computational inputs. Experts warn this is a dual-use technology: methods that could aid antibiotic alternatives might also be adapted for harmful pathogens, prompting calls for stronger oversight and safeguards.
Published by Banx Network. This article is part of the Banx decentralized media programme, powered by the BXE token on the XRP Ledger.





